Eric Groen

General Counsel, Rani Therapeutics Holdings, Inc.

Companies

GENELUX CorpGeneral counsel Jul 2, 2025 to now¹
Rani Therapeutics Holdings, Inc.General counsel Mar 24, 2022 to Mar 22, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

GENELUX Corp GNLX233,957 shares³$576.7K at $2.47Jun 16, 2026
Rani Therapeutics Holdings, Inc. RANI163,216 shares⁴$106.9K at $0.66Mar 27, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 16, 2026Granted 233,957 shares of GENELUX Corp³
Mar 27, 2023Granted 139,000 shares of Rani Therapeutics Holdings, Inc.⁴
Mar 22, 2023Shares withheld for tax 2,498 shares at $5.95 of Rani Therapeutics Holdings, Inc.⁵
Mar 22, 2022Granted 24,500 shares of Rani Therapeutics Holdings, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGENELUX Corp, General counsel
2
SEC EDGARRani Therapeutics Holdings, Inc., General counsel
3
SEC EDGARGENELUX Corp shares after the filing of Jun 16, 2026
4
SEC EDGARRani Therapeutics Holdings, Inc. shares after the filing of Mar 27, 2023
5
SEC EDGARForm 4 filed Mar 24, 2023
6
SEC EDGARForm 4 filed Mar 24, 2022